PRIA, Government Policy, Made Personal

Summary

Gives the Director of the Office of National Drug Control Policy, working with the head of SAMHSA, the power to award grants to community groups to fight sudden or ongoing local problems with opioids or methamphetamines. To get a grant, a group must already have had a Drug‑Free Communities Act grant and must show local data that opioid or meth use is much higher than the national average or has been higher for a long time. Applicants must send a plan that brings together local partners from many sectors. Grant money must pay for community‑wide prevention and response work, help pay for specialized training from the organization funded under section 4 of Public Law 107–82, and address new drug problems. Federal funds must add to, not replace, other money. No more than 8 percent of the grant money each year may be used for admin costs. Grants will be evaluated like Drug‑Free Communities grants and may include reviews of opioid and meth use. The Director may let SAMHSA help run the grants. Congress authorized $5,000,000 for each of fiscal years 2017 through 2021. Definitions (one line each): Administrator = head of SAMHSA; Director = head of ONDCP; Drug‑Free Communities Act = the named federal program chapter; Eligible entity = a group that has a Drug‑Free Communities grant and local data showing high opioid/meth problems; Emerging drug abuse issue = a sudden rise in treatment need and not enough local resources; Local drug crisis = a sudden rise in opioid/meth use or deaths, or sustained higher rates; Opioid = a drug like morphine or convertible into one.

Title 21, §1536

Food and Drugs, Source: USLM XML via OLRC

(a)Definitions

In this section: (1) Administrator (2) Director (3) Drug-Free Communities Act of 1997

(4)Eligible entity

The term “eligible entity” means an organization that—

(A)on or before the date of submitting an application for a grant under this section, receives or has received a grant under the Drug-Free Communities Act of 1997; and

(B)has documented, using local data, rates of abuse of opioids or methamphetamines at levels that are—

(i)significantly higher than the national average as determined by the Secretary (including appropriate consideration of the results of the Monitoring the Future Survey published by the National Institute on Drug Abuse and the National Survey on Drug Use and Health published by the Substance Abuse and Mental Health Services Administration); or

(ii)higher than the national average, as determined by the Secretary (including appropriate consideration of the results of the surveys described in clause (i)), over a sustained period of time.

(5)Emerging drug abuse issue

The term “emerging drug abuse issue” means a substance use disorder within an area involving—

(A)a sudden increase in demand for particular drug abuse treatment services relative to previous demand; and

(B)a lack of resources in the area to address the emerging problem.

(6)Local drug crisis

The term “local drug crisis” means, with respect to the area served by an eligible entity—

(A)a sudden increase in the abuse of opioids or methamphetamines, as documented by local data;

(B)the abuse of prescription medications, specifically opioids or methamphetamines, that is significantly higher than the national average, over a sustained period of time, as documented by local data; or

(C)a sudden increase in opioid-related deaths, as documented by local data.

(7)Opioid

The term “opioid” means any drug having an addiction-forming or addiction-sustaining liability similar to morphine or being capable of conversion into a drug having such addiction-forming or addiction-sustaining liability.

(b)Program authorized

The Director, in coordination with the Administrator, may make grants to eligible entities to implement comprehensive community-wide strategies that address local drug crises and emerging drug abuse issues within the area served by the eligible entity.

(c)Application

(1)In general

An eligible entity seeking a grant under this section shall submit an application to the Director at such time, in such manner, and accompanied by such information as the Director may require.

(2)Criteria

As part of an application for a grant under this section, the Director shall require an eligible entity to submit a detailed, comprehensive, multisector plan for addressing the local drug crisis or emerging drug abuse issue within the area served by the eligible entity.

(d)Use of funds

An eligible entity shall use a grant received under this section— (1)

(2)to obtain specialized training and technical assistance from the organization funded under section 4 of Public Law 107–82 (21 U.S.C. 1521 note); and

(3)for programs designed to implement comprehensive community-wide strategies to address emerging drug abuse issues in the community.

(e)Supplement not supplant

An eligible entity shall use Federal funds received under this section only to supplement the funds that would, in the absence of those Federal funds, be made available from other Federal and non-Federal sources for the activities described in this section, and not to supplant those funds.

(f)Evaluation

A grant under this section shall be subject to the same evaluation requirements and procedures as the evaluation requirements and procedures imposed on the recipient of a grant under the Drug-Free Communities Act of 1997, and may also include an evaluation of the effectiveness at reducing abuse of opioids or methamphetamines.

(g)Limitation on administrative expenses

Not more than 8 percent of the amounts made available to carry out this section for a fiscal year may be used to pay for administrative expenses.

(h)Delegation authority

The Director may enter into an interagency agreement with the Administrator to delegate authority for the execution of grants and for such other activities as may be necessary to carry out this section.

(i)Authorization of appropriations

For the purpose of carrying out this section, there are authorized to be appropriated $5,000,000 for each of fiscal years 2017 through 2021.

Notes & Related Subsidiaries

Editorial Notes

References in Text

The Drug-Free Communities Act of 1997, referred to in subsec. (a)(3), is Pub. L. 105–20, June 27, 1997, 111 Stat. 224, section 2(a)(2) of which enacted chapter 2 of the National Narcotics Leadership Act of 1988, which is classified to this subchapter. For complete classification of the Drug-Free Communities Act of 1997 to the Code, see

Short Title

of 1997 Amendment note set out under section 1501 of this title and Tables. Codification Section was enacted as part of the Comprehensive Addiction and Recovery Act of 2016, and not as part of the National Narcotics Leadership Act of 1988 which comprises this chapter.

§1536 Community-based Coalition Enhancement Grants to Address Local Drug Crises